Poor Economic Incentives Have Left Doctors Without New Antibiotics

Medical researchers have known for decades that the pipeline for new drugs to stave off bacterial infections would one day run dry. That day is now at hand.

In some cases, doctors have no drugs to give their patients for what once were treatable infections but are now life-threatening. Although researchers have many good leads, the bigger problem is a lack of financial incentives to bring new treatments through the drug-development gantlet.

"When I signed up to be an infectious about the drug-resistance problem and how we might dig our way out of it.